S. E. Wolkenberg

2.8k citations

52 papers · 2.2k indexed · h-index 24

Impact in

Organic Chemistry top 1%
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
- Synthesis and biological activity
- Catalytic C–H Functionalization Methods
- Click Chemistry and Applications
- Microwave-Assisted Synthesis and Applications
Toxicology top 2%

Papers in

Organic Chemistry 26
- Microwave-Assisted Synthesis and Applications 9
- Synthesis and Biological Evaluation 7
- Multicomponent Synthesis of Heterocycles 4
Biochemistry 5
- Amino Acid Enzymes and Metabolism 5

Co-authors: Dale L. Boger Craig W. Lindsley Zhijian Zhao David D. Wisnoski William Leister Yi Wang William D. Shipe Cyrille Sur
Journals: Bioorganic & Medicinal Chemistry Letters (9 papers)ACS Medicinal Chemistry Letters (8 papers)Journal of the American Chemical Society (6 papers)Current Topics in Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (3 papers)
Partner nations: United States Italy United Kingdom

In The Last Decade

S. E. Wolkenberg

52 papers receiving 2.1k citations

Peers

Countries citing papers authored by S. E. Wolkenberg

Since Specialization

Citations

This map shows the geographic impact of S. E. Wolkenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Wolkenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Wolkenberg more than expected).

Fields of papers citing papers by S. E. Wolkenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. E. Wolkenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Wolkenberg. The network helps show where S. E. Wolkenberg may publish in the future.

Co-authors

The 25 scholars most cited alongside S. E. Wolkenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. E. Wolkenberg Line = papers co-authored together S. E. Wolkenberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Enabling Deoxygenative C(sp²)-C(sp³) Cross-Coupling for Parallel Medicinal Chemistry ACS Medicinal Chemistry Letters ·Wei Liu, Eva-Maria Herring, Bo Hao, Santiago Cañellas, Stefaan Last, José Enrique Gómez, Yucui Xing, Jorge Rezende Filho, Kiran Kumar, H. Malawska, 征央伊賀, Iulia I. Strambeanu, S. E. Wolkenberg	2023	12
2	Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation Bioorganic & Medicinal Chemistry Letters ·Wensheng Yu, Jian Liu, Younong Yu, Vivian Zhang, Dane J. Clausen, Joseph Kelly, S. E. Wolkenberg, Douglas C. Beshore, Joseph Duffy, Caroline Chung, Robert W. Myers, Daniel J. Klein, James I. Fells, A. Yu. Pulyalina, Jin Wu, Guoxin Wu, Bonnie J. Howell, Richard J. O. Barnard, Joseph A. Kozlowski	2020	22
3	Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, Scott T. Harrison, Перетятко Сабина Андреевна, John M. Sanders, P.C. Conor, Breanna J. Nickel, Debra A. McLoughlin, Christopher R. Gibson, R. Robinson, Nancy A. Sachs, Monika Kandebo, Lihang Yao, Sean M. Smith, Pete H. Hutson, S. E. Wolkenberg, James C. Barrow	2016	10
4	Developing and applying ultrasensitive p24 protein immunoassay for HIV latency Journal of Virus Eradication ·Bonnie J. Howell, Guoxin Wu, Meghan R. Swanson, Meiqing Lu, Jesús Arenas Esteban, Julie Strizki, S. E. Wolkenberg, Richard J. O. Barnard, Wade Blair, Daria J. Hazuda	2015	5
5	[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey Nuclear Medicine and Biology ·Eric D. Hostetler, Sandra Sanabria Bohórquez, Hong Fan, Zhizhen Zeng, M. Hatzis, Patricia Miller, Stacey O’Malley, Brett Connolly, Eva-Maria Herring, Scott T. Harrison, S. E. Wolkenberg, James C. Barrow, David L. Williams, Richard Hargreaves, Cyrille Sur, Jacquelynn J. Cook	2011	22
6	High concentration electrophysiology-based fragment screen: Discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, Eva-Maria Herring, Scott T. Harrison, John M. Sanders, Matthew J. Cato, Aneta Jovanovska, R Innamorati, Sean P. Cook, Darrell A. Henze, Stefanie A. Kane, George D. Hartman, James C. Barrow	2010	17
7	Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors Current Topics in Medicinal Chemistry ·S. E. Wolkenberg, Cyrille Sur	2010	23
8	The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK‐6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracers Synapse ·Terence G. Hamill, Waisi Eng, Charlotte Johannsen, Richard Lewis, Steven Thomas, Maria Isabel Fernandes Torquato de Sá, Leslie J. Street, David D. Wisnoski, S. E. Wolkenberg, Craig W. Lindsley, Sandra Sanabria Bohórquez, Shil Patel, Kerry Riffel, Christine Ryan, Jacquelynn J. Cook, Cyrille Sur, H. Donald Burns, Richard Hargreaves	2010	27
9	Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, William Leister, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, George D. Hartman, Craig W. Lindsley, S. E. Wolkenberg	2009	16
10	Discovery of GlyT1 inhibitors with improved pharmacokinetic properties Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, David D. Wisnoski, William Leister, Richard Bryant, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, Christopher R. Gibson, Bennett Ma, P.C. Conor, Craig W. Lindsley, George D. Hartman	2009	15
11	Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs) Bioorganic & Medicinal Chemistry Letters ·S.A. KONDRAT'EV, S. E. Wolkenberg, Meiqing Lu, Vandna Munshi, Gregory Moyer, Meizhen Feng, Anthony Carella, V VMyllylä, Lori J. Gabryelski, 王思霞, Sydney T. Wickett, Youwei Yan, Georgia B. McGaughey, Michael D. Miller, Craig W. Lindsley, George D. Hartman, Jesua S. Salcedo-Castañeda, 株式会社タダノ	2007	76
12	Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, George D. Hartman, S. E. Wolkenberg, Craig W. Lindsley	2006	12
13	Potent antagonists of the Kv1.5 potassium channel: Synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides Bioorganic & Medicinal Chemistry Letters ·Kausik K. Nanda, Juan Moncada, Matthew J. Cato, Stefanie A. Kane, László Kiss, Robert H. Spencer, Jixin Wang, Joseph J. Lynch, Christopher P. Regan, Gary L. Stump, Bing Li, Rebecca B. White, Suzie Yeh, Michael J. Bogusky, Mark T. Bilodeau, Christopher J. Dinsmore, Craig W. Lindsley, George D. Hartman, S. E. Wolkenberg, B. Wesley Trotter	2006	11
14	Identification of potent agonists of photoreceptor-specific nuclear receptor (NR2E3) and preparation of a radioligand Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, Marianna Kapitskaya, Andrea L. Webber, Konstantin Petrukhin, Yui S. Tang, Dennis Dean, George D. Hartman, Craig W. Lindsley	2006	27
15	Progress in the Preparation and Testing of Glycine Transporter Type-1 (GlyT1) Inhibitors Current Topics in Medicinal Chemistry ·Craig W. Lindsley, S. E. Wolkenberg, Gene G. Kinney	2006	29
16	Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia Current Topics in Medicinal Chemistry ·Craig W. Lindsley, William D. Shipe, S. E. Wolkenberg, Cory R. Theberge, David L. Williams, Cyrille Sur, Gene G. Kinney	2006	125
17	Accelerating lead development by microwave-enhanced medicinal chemistry Drug Discovery Today Technologies ·William D. Shipe, S. E. Wolkenberg, Craig W. Lindsley	2005	49
18	DNA Alkylation Properties of Yatakemycin Journal of the American Chemical Society ·Jay P. Parrish, David B. Kastrinsky, S. E. Wolkenberg, Yasuhiro Igarashi, Dale L. Boger	2003	76
19	Metal Cation Complexation and Activation of Reversed CPyI Analogues of CC-1065 and Duocarmycin SA: Partitioning the Effects of Binding and Catalysis Journal of the American Chemical Society ·David A. Ellis, S. E. Wolkenberg, Dale L. Boger	2001	18
20	Synthesis and Evaluation of 1,2,8,8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the Parent Alkylation Subunit of CC-1065 and the Duocarmycins: Impact of the Alkylation Subunit Substituents and Its Implications for DNA Alkylation Catalysis The Journal of Organic Chemistry ·Dale L. Boger, Alejandro Santillán, Mark Searcey, S.R. Brunette, S. E. Wolkenberg, Michael P. Hedrick, Qing Jin	2000	27

About S. E. Wolkenberg

S. E. Wolkenberg is a scholar working on Organic Chemistry, Biochemistry, Cellular and Molecular Neuroscience, Virology and Biological Psychiatry, having authored 52 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (10 papers), Microwave-Assisted Synthesis and Applications (9 papers), Synthesis and Biological Evaluation (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Amino Acid Enzymes and Metabolism (5 papers), Cancer therapeutics and mechanisms (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Multicomponent Synthesis of Heterocycles (4 papers). The work is most often cited by research in Organic Chemistry (1.4k citations), Toxicology (81 citations), Biochemistry (129 citations), Cellular and Molecular Neuroscience (232 citations) and Biological Psychiatry (31 citations). S. E. Wolkenberg has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Dale L. Boger, Craig W. Lindsley, Zhijian Zhao, David D. Wisnoski, William Leister, Yi Wang, William D. Shipe, Cyrille Sur, Gene G. Kinney and David L. Williams. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Journal of the American Chemical Society, Current Topics in Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact